APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

In-Vitro Colorectal Cancer Screening Tests

In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.

Selected research

Market Analysis & Forecast

Global In-Vitro Colorectal Cancer Screening Tests Market Analysis and Forecast 2026-2032

Report ID 173894510227 December 2025198 pages

Choose your research edition.

Industry ResearchIn-Vitro Colorectal Cancer Screening Tests Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal In-Vitro Colorectal Cancer Screening Tests Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal In-Vitro Colorectal Cancer Screening Tests Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal In-Vitro Colorectal Cancer Screening Tests Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal In-Vitro Colorectal Cancer Screening Tests Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.

The industry's leading producers are Alere(Abbott), Beckman Coulter and Siemens Healthcare, which accounted for 31.59%, 18.71% and 10.67% of revenue in 2019, respectively.

Report Includes

Read the full market overview

This report presents an overview of global market for In-Vitro Colorectal Cancer Screening Tests, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of In-Vitro Colorectal Cancer Screening Tests, also provides the revenue of main regions and countries. Of the upcoming market potential for In-Vitro Colorectal Cancer Screening Tests, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the In-Vitro Colorectal Cancer Screening Tests revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global In-Vitro Colorectal Cancer Screening Tests market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for In-Vitro Colorectal Cancer Screening Tests revenue, projected growth trends, production technology, application and end-user industry.

In-Vitro Colorectal Cancer Screening Tests Segment by Company

Alere(Abbott)

Beckman Coulter

Siemens Healthcare

Eiken Chemical

Hitachi Chemical (Kyowa Medex)

Clinical Genomics Pty Ltd (Quest Diagnostics)

Sysmex

QIAGEN

R-Biopharm

Immunostics

In-Vitro Colorectal Cancer Screening Tests Segment by Type

Biomarker Tests

Fecal Occult Blood Tests

CRC DNA Screening Tests

In-Vitro Colorectal Cancer Screening Tests Segment by Application

Hospital and Clinics

Ambulatory

Home Care

In-Vitro Colorectal Cancer Screening Tests Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-Vitro Colorectal Cancer Screening Tests market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of In-Vitro Colorectal Cancer Screening Tests and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-Vitro Colorectal Cancer Screening Tests.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of In-Vitro Colorectal Cancer Screening Tests in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of In-Vitro Colorectal Cancer Screening Tests company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In-Vitro Colorectal Cancer Screening Tests revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Biomarker Tests Major Player Table 3. Fecal Occult Blood Tests Major Player Table 4. CRC DNA Screening Tests Major Player Table 5. Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital and Clinics Major Player Table 7. Ambulatory Major Player Table 8. Home Care Major Player Table 9. In-Vitro Colorectal Cancer Screening Tests Industry Trends Table 10. In-Vitro Colorectal Cancer Screening Tests Industry Drivers Table 11. In-Vitro Colorectal Cancer Screening Tests Industry Opportunities and Challenges Table 12. In-Vitro Colorectal Cancer Screening Tests Industry Restraints Table 13. Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Region (2021-2026) & (US$ Million) Table 15. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Region (2021-2026) Table 16. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Region (2027-2032) & (US$ Million) Table 17. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Region (2027-2032) Table 18. Global In-Vitro Colorectal Cancer Screening Tests Revenue by Players (US$ Million) & (2021-2026) Table 19. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Players (2021-2026) Table 20. Global In-Vitro Colorectal Cancer Screening Tests Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global In-Vitro Colorectal Cancer Screening Tests Key Players Headquarters & Area Served Table 22. Global In-Vitro Colorectal Cancer Screening Tests Players, Product Type & Application Table 23. Global In-Vitro Colorectal Cancer Screening Tests Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global In-Vitro Colorectal Cancer Screening Tests by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global In-Vitro Colorectal Cancer Screening Tests Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2021-2026) & (US$ Million) Table 28. Global In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2027-2032) & (US$ Million) Table 29. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Type (2021-2026) Table 30. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Type (2027-2032) Table 31. Global In-Vitro Colorectal Cancer Screening Tests Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2021-2026) & (US$ Million) Table 33. Global In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2027-2032) & (US$ Million) Table 34. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application (2021-2026) Table 35. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application (2027-2032) Table 36. Alere(Abbott) Company Information Table 37. Alere(Abbott) Business Overview Table 38. Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Product Portfolio Table 40. Alere(Abbott) Recent Development Table 41. Beckman Coulter Company Information Table 42. Beckman Coulter Business Overview Table 43. Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Product Portfolio Table 45. Beckman Coulter Recent Development Table 46. Siemens Healthcare Company Information Table 47. Siemens Healthcare Business Overview Table 48. Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Product Portfolio Table 50. Siemens Healthcare Recent Development Table 51. Eiken Chemical Company Information Table 52. Eiken Chemical Business Overview Table 53. Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Product Portfolio Table 55. Eiken Chemical Recent Development Table 56. Hitachi Chemical (Kyowa Medex) Company Information Table 57. Hitachi Chemical (Kyowa Medex) Business Overview Table 58. Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Product Portfolio Table 60. Hitachi Chemical (Kyowa Medex) Recent Development Table 61. Clinical Genomics Pty Ltd (Quest Diagnostics) Company Information Table 62. Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview Table 63. Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Product Portfolio Table 65. Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Development Table 66. Sysmex Company Information Table 67. Sysmex Business Overview Table 68. Sysmex In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Sysmex In-Vitro Colorectal Cancer Screening Tests Product Portfolio Table 70. Sysmex Recent Development Table 71. QIAGEN Company Information Table 72. QIAGEN Business Overview Table 73. QIAGEN In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. QIAGEN In-Vitro Colorectal Cancer Screening Tests Product Portfolio Table 75. QIAGEN Recent Development Table 76. R-Biopharm Company Information Table 77. R-Biopharm Business Overview Table 78. R-Biopharm In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. R-Biopharm In-Vitro Colorectal Cancer Screening Tests Product Portfolio Table 80. R-Biopharm Recent Development Table 81. Immunostics Company Information Table 82. Immunostics Business Overview Table 83. Immunostics In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Immunostics In-Vitro Colorectal Cancer Screening Tests Product Portfolio Table 85. Immunostics Recent Development Table 86. North America In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2021-2026) & (US$ Million) Table 87. North America In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2027-2032) & (US$ Million) Table 88. North America In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2021-2026) & (US$ Million) Table 89. North America In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2027-2032) & (US$ Million) Table 90. North America In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2021-2026) & (US$ Million) Table 92. North America In-Vitro Colorectal Cancer Screening Tests Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Country (US$ Million) & (2027-2032) Table 100. China In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2021-2026) & (US$ Million) Table 101. China In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2027-2032) & (US$ Million) Table 102. China In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2021-2026) & (US$ Million) Table 103. China In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia In-Vitro Colorectal Cancer Screening Tests Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia In-Vitro Colorectal Cancer Screening Tests Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia In-Vitro Colorectal Cancer Screening Tests Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. In-Vitro Colorectal Cancer Screening Tests Image Figure 2. Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global In-Vitro Colorectal Cancer Screening Tests Market Size Share 2021 VS 2025 VS 2032 Figure 4. Biomarker Tests Image Figure 5. Fecal Occult Blood Tests Image Figure 6. CRC DNA Screening Tests Image Figure 7. Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global In-Vitro Colorectal Cancer Screening Tests Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital and Clinics Image Figure 10. Ambulatory Image Figure 11. Home Care Image Figure 12. Global In-Vitro Colorectal Cancer Screening Tests Market Size (US$ Million) & (2021-2032) Figure 13. Global In-Vitro Colorectal Cancer Screening Tests Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global In-Vitro Colorectal Cancer Screening Tests Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Type (2021-2032) Figure 20. Global In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application (2021-2032) Figure 23. North America In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America In-Vitro Colorectal Cancer Screening Tests Revenue Share by Type (2021-2032) Figure 25. North America In-Vitro Colorectal Cancer Screening Tests Revenue Share by Application (2021-2032) Figure 26. North America In-Vitro Colorectal Cancer Screening Tests Revenue Share by Country (2021-2032) Figure 27. United States In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe In-Vitro Colorectal Cancer Screening Tests Revenue Share by Type (2021-2032) Figure 32. Europe In-Vitro Colorectal Cancer Screening Tests Revenue Share by Application (2021-2032) Figure 33. Europe In-Vitro Colorectal Cancer Screening Tests Revenue Share by Country (2021-2032) Figure 34. Germany In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China In-Vitro Colorectal Cancer Screening Tests Revenue Share by Type (2021-2032) Figure 44. China In-Vitro Colorectal Cancer Screening Tests Revenue Share by Application (2021-2032) Figure 45. Asia In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia In-Vitro Colorectal Cancer Screening Tests Revenue Share by Type (2021-2032) Figure 47. Asia In-Vitro Colorectal Cancer Screening Tests Revenue Share by Application (2021-2032) Figure 48. Asia In-Vitro Colorectal Cancer Screening Tests Revenue Share by Region (2021-2032) Figure 49. Japan In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue Share by Type (2021-2032) Figure 57. SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue Share by Application (2021-2032) Figure 58. SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue Share by Country (2021-2032) Figure 59. Brazil In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt In-Vitro Colorectal Cancer Screening Tests Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Biomarker Tests
  • Fecal Occult Blood Tests
  • CRC DNA Screening Tests
Applications
  • Hospital and Clinics
  • Ambulatory
  • Home Care
Companies covered
  • Alere(Abbott)
  • Beckman Coulter
  • Siemens Healthcare
  • Eiken Chemical
  • Hitachi Chemical (Kyowa Medex)
  • Clinical Genomics Pty Ltd (Quest Diagnostics)
  • Sysmex
  • QIAGEN
  • R-Biopharm
  • Immunostics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 In-Vitro Colorectal Cancer Screening Tests Market by Type
  3. 1.2.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Biomarker Tests
  5. 1.2.3 Fecal Occult Blood Tests
  6. 1.2.4 CRC DNA Screening Tests
  7. 1.3 In-Vitro Colorectal Cancer Screening Tests Market by Application
  8. 1.3.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital and Clinics
  10. 1.3.3 Ambulatory
  11. 1.3.4 Home Care
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 In-Vitro Colorectal Cancer Screening Tests Market Dynamics
  1. 2.1 In-Vitro Colorectal Cancer Screening Tests Industry Trends
  2. 2.2 In-Vitro Colorectal Cancer Screening Tests Industry Drivers
  3. 2.3 In-Vitro Colorectal Cancer Screening Tests Industry Opportunities and Challenges
  4. 2.4 In-Vitro Colorectal Cancer Screening Tests Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global In-Vitro Colorectal Cancer Screening Tests Market Perspective (2021-2032)
  2. 3.2 Global In-Vitro Colorectal Cancer Screening Tests Growth Trends by Region
  3. 3.2.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Region (2021-2026)
  5. 3.2.3 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue by Players
  2. 4.1.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue by Players (2021-2026)
  3. 4.1.2 Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global In-Vitro Colorectal Cancer Screening Tests Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global In-Vitro Colorectal Cancer Screening Tests Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global In-Vitro Colorectal Cancer Screening Tests Key Players Headquarters & Area Served
  7. 4.4 Global In-Vitro Colorectal Cancer Screening Tests Players, Product Type & Application
  8. 4.5 Global In-Vitro Colorectal Cancer Screening Tests Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global In-Vitro Colorectal Cancer Screening Tests Market CR5 and HHI
  11. 4.6.3 2025 In-Vitro Colorectal Cancer Screening Tests Tier 1, Tier 2, and Tier 3
5 In-Vitro Colorectal Cancer Screening Tests Market Size by Type
  1. 5.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2021-2032)
  3. 5.3 Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Type (2021-2032)
6 In-Vitro Colorectal Cancer Screening Tests Market Size by Application
  1. 6.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2021-2032)
  3. 6.3 Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Alere(Abbott)
  2. 7.1.1 Alere(Abbott) Company Information
  3. 7.1.2 Alere(Abbott) Business Overview
  4. 7.1.3 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Product Portfolio
  6. 7.1.5 Alere(Abbott) Recent Developments
  7. 7.2 Beckman Coulter
  8. 7.2.1 Beckman Coulter Company Information
  9. 7.2.2 Beckman Coulter Business Overview
  10. 7.2.3 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Product Portfolio
  12. 7.2.5 Beckman Coulter Recent Developments
  13. 7.3 Siemens Healthcare
  14. 7.3.1 Siemens Healthcare Company Information
  15. 7.3.2 Siemens Healthcare Business Overview
  16. 7.3.3 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Product Portfolio
  18. 7.3.5 Siemens Healthcare Recent Developments
  19. 7.4 Eiken Chemical
  20. 7.4.1 Eiken Chemical Company Information
  21. 7.4.2 Eiken Chemical Business Overview
  22. 7.4.3 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Product Portfolio
  24. 7.4.5 Eiken Chemical Recent Developments
  25. 7.5 Hitachi Chemical (Kyowa Medex)
  26. 7.5.1 Hitachi Chemical (Kyowa Medex) Company Information
  27. 7.5.2 Hitachi Chemical (Kyowa Medex) Business Overview
  28. 7.5.3 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Product Portfolio
  30. 7.5.5 Hitachi Chemical (Kyowa Medex) Recent Developments
  31. 7.6 Clinical Genomics Pty Ltd (Quest Diagnostics)
  32. 7.6.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Company Information
  33. 7.6.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview
  34. 7.6.3 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Product Portfolio
  36. 7.6.5 Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Developments
  37. 7.7 Sysmex
  38. 7.7.1 Sysmex Company Information
  39. 7.7.2 Sysmex Business Overview
  40. 7.7.3 Sysmex In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Sysmex In-Vitro Colorectal Cancer Screening Tests Product Portfolio
  42. 7.7.5 Sysmex Recent Developments
  43. 7.8 QIAGEN
  44. 7.8.1 QIAGEN Company Information
  45. 7.8.2 QIAGEN Business Overview
  46. 7.8.3 QIAGEN In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (2021-2026)
  47. 7.8.4 QIAGEN In-Vitro Colorectal Cancer Screening Tests Product Portfolio
  48. 7.8.5 QIAGEN Recent Developments
  49. 7.9 R-Biopharm
  50. 7.9.1 R-Biopharm Company Information
  51. 7.9.2 R-Biopharm Business Overview
  52. 7.9.3 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (2021-2026)
  53. 7.9.4 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Product Portfolio
  54. 7.9.5 R-Biopharm Recent Developments
  55. 7.10 Immunostics
  56. 7.10.1 Immunostics Company Information
  57. 7.10.2 Immunostics Business Overview
  58. 7.10.3 Immunostics In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Immunostics In-Vitro Colorectal Cancer Screening Tests Product Portfolio
  60. 7.10.5 Immunostics Recent Developments
8 North America
  1. 8.1 North America In-Vitro Colorectal Cancer Screening Tests Revenue (2021-2032)
  2. 8.2 North America In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2021-2032)
  3. 8.2.1 North America In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2021-2026)
  4. 8.2.2 North America In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2027-2032)
  5. 8.3 North America In-Vitro Colorectal Cancer Screening Tests Revenue Share by Type (2021-2032)
  6. 8.4 North America In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2021-2032)
  7. 8.4.1 North America In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2021-2026)
  8. 8.4.2 North America In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2027-2032)
  9. 8.5 North America In-Vitro Colorectal Cancer Screening Tests Revenue Share by Application (2021-2032)
  10. 8.6 North America In-Vitro Colorectal Cancer Screening Tests Revenue by Country
  11. 8.6.1 North America In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2021-2026)
  13. 8.6.3 North America In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe In-Vitro Colorectal Cancer Screening Tests Revenue (2021-2032)
  2. 9.2 Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2021-2032)
  3. 9.2.1 Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2021-2026)
  4. 9.2.2 Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2027-2032)
  5. 9.3 Europe In-Vitro Colorectal Cancer Screening Tests Revenue Share by Type (2021-2032)
  6. 9.4 Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2021-2032)
  7. 9.4.1 Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2021-2026)
  8. 9.4.2 Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2027-2032)
  9. 9.5 Europe In-Vitro Colorectal Cancer Screening Tests Revenue Share by Application (2021-2032)
  10. 9.6 Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Country
  11. 9.6.1 Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2021-2026)
  13. 9.6.3 Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China In-Vitro Colorectal Cancer Screening Tests Revenue (2021-2032)
  2. 10.2 China In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2021-2032)
  3. 10.2.1 China In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2021-2026)
  4. 10.2.2 China In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2027-2032)
  5. 10.3 China In-Vitro Colorectal Cancer Screening Tests Revenue Share by Type (2021-2032)
  6. 10.4 China In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2021-2032)
  7. 10.4.1 China In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2021-2026)
  8. 10.4.2 China In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2027-2032)
  9. 10.5 China In-Vitro Colorectal Cancer Screening Tests Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia In-Vitro Colorectal Cancer Screening Tests Revenue (2021-2032)
  2. 11.2 Asia In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2021-2032)
  3. 11.2.1 Asia In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2021-2026)
  4. 11.2.2 Asia In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2027-2032)
  5. 11.3 Asia In-Vitro Colorectal Cancer Screening Tests Revenue Share by Type (2021-2032)
  6. 11.4 Asia In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2021-2032)
  7. 11.4.1 Asia In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2021-2026)
  8. 11.4.2 Asia In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2027-2032)
  9. 11.5 Asia In-Vitro Colorectal Cancer Screening Tests Revenue Share by Application (2021-2032)
  10. 11.6 Asia In-Vitro Colorectal Cancer Screening Tests Revenue by Country
  11. 11.6.1 Asia In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2021-2026)
  13. 11.6.3 Asia In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue (2021-2032)
  2. 12.2 SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2027-2032)
  5. 12.3 SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2027-2032)
  9. 12.5 SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue by Country
  11. 12.6.1 SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst